We are live on
!
Find out more
NBG
Nancy B. Gardiner Portfolio holdings
AUM
$60.4M
1-Year Est. Return
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+13.19%
3 Year Est. Return
+51.16%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.9M
AUM Growth
-$2.33M
(-3.8%)
Cap. Flow
-$2.49M
Cap. Flow
% of AUM
-4.23%
Top 10 Holdings %
Top 10 Hldgs %
33.67%
Holding
71
New
1
Increased
13
Reduced
34
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$347K |
| 2 |
Illumina
ILMN
|
+$204K |
| 3 |
Ormat Technologies
ORA
|
+$196K |
| 4 |
TJX Companies
TJX
|
+$113K |
| 5 |
Microsoft
MSFT
|
+$98.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enanta Pharmaceuticals
ENTA
|
+$1.41M |
| 2 |
EOG Resources
EOG
|
+$254K |
| 3 |
Oracle
ORCL
|
+$242K |
| 4 |
IPG Photonics
IPGP
|
+$220K |
| 5 |
Mastercard
MA
|
+$142K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.8% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 11.02% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Staples | 10.73% |
Similar funds
FC
SCM
MVM
LM
EGPO
TC
PC
AIS
Nancy B. Gardiner's Q3 2019 Portfolio in Review
As of Q3 2019, Nancy B. Gardiner held 71 positions worth $58.9M, down 3.8% from $61.3M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Nancy B. Gardiner withdrew a net $2.49M in Q3 2019, closing 4 positions and reducing 34 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $1.41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nancy B. Gardiner opened a new position in Ormat Technologies worth $211K.
- Nancy B. Gardiner's largest Q3 2019 buy was Ormat Technologies: 2,840 shares worth $211K.
- Nancy B. Gardiner added most to Becton Dickinson in Q3 2019, an estimated $347K increase.
- Nancy B. Gardiner's biggest Q3 2019 reduction was Mastercard, cutting an estimated $142K.
- Nancy B. Gardiner fully exited Enanta Pharmaceuticals in Q3 2019, selling an estimated $1.41M.
- Nancy B. Gardiner's ten largest holdings make up 34% of its $58.9M portfolio in Q3 2019.
- Nancy B. Gardiner opened 1 new position and closed 4 in Q3 2019.
- Nancy B. Gardiner's portfolio value fell 3.8% quarter-over-quarter to $58.9M.
Based on Nancy B. Gardiner's 13F filing for Q3 2019, filed 6 Nov 2019.